ZMUni Compliance Centre

Recently, ZMUni Compliance Centre successfully supported Scientis in securing approval for its Cyspera® product in China, a Special Cosmetic product with whitening and freckle-removing claims.   Compared with general cosmetics, Special Cosmetics in China are subject to more stringent regulatory requirements, requiring extensive technical documentation, detailed formulation review, safety assessment, efficacy evaluation, and regulatory compliance review. ZMUni provided end-to-end regulatory support throughout the registration process, including dossier preparation and review, compliance assessment, submission support, and regulatory follow-up.   Leveraging its regulatory expertise and efficient project management, ZMUni supported Scientis in successfully completing the registration process and obtaining approval on the

Recently, ZMUni Compliance Centre successfully supported XtalPi Holdings Limited (2228.HK) in securing a U.S. Self-affirmed GRAS determination for Tensotide™, an innovative oral peptide ingredient designed for blood glucose management. Developed through XtalPi's proprietary AI-powered peptide platform PepiX™, Tensotide™ is now cleared for lawful use in foods and dietary supplements in the United States, enabling a significant step forward in its global commercialization pathway.   This milestone represents another key achievement for XtalPi in the consumer health space and highlights ZMUni Compliance Centre's strong capabilities in overseas food regulatory compliance and international market access for novel and innovative ingredients, consistently enabling

Recently, ZMUni Compliance Centre has successfully supported multiple cosmetic brands in navigating and completing regulatory compliance across key global markets—including the United States (and California), Canada, Taiwan (China), Japan, ASEAN (Malaysia, Indonesia, Thailand, Vietnam), and the United Kingdom.   These projects cover a wide range of cosmetic categories, from skincare products such as moisturisers, cleansers, anti-aging, and brightening formulations, to colour cosmetics, haircare, and full-range personal care products.     United States   Our recent compliance achievements in the US market span a diverse range of product categories, including moisturisers, skincare gels and oils, cleansing gels/milks, hydrating masks, serums, clay

ZMUni Compliance Center has recently supported two overseas food manufacturers in successfully completing registration with China’s General Administration of Customs (GACC) as overseas manufacturers of imported food, enabling compliant access to the Chinese market.      Case 1 | LLC First Alive Collagen & Hydrolyzed Collagen Products (Russia)      ZMUni supported LLC "First Alive Collagen" in completing its GACC registration as an overseas food production enterprise. With the registration approved, the company is now eligible to export hydrolyzed collagen products to China, enabling compliant import and customs clearance.   First Alive Collagen is a Russian biotechnology company focused on collagen-based

From March 18 to 20, 2026, PCHi 2026 took place in Hangzhou, bringing together a wide range of industry players across the cosmetic, personal care, and home care sectors. This year's edition featured over 860 exhibitors from 26 countries and regions, with exhibition space exceeding 70,000 square meters, and attracted professional visitors from more than 70 countries worldwide.   As one of the leading global events for cosmetic ingredients and related industries, PCHi continues to serve as an important platform for industry exchange and international collaboration.       During the exhibition, Chris Wang, Senior Regulatory Analyst & Head of

On March 17, 2026, ZMUni hosted its "Global Cosmetic Compliance Development & Practice 2026" seminar in Hangzhou, right in the heart of PCHi 2026 week. Over 100 industry professionals joined us to explore the latest regulatory trends, compliance strategies, and practical insights for navigating both China's dynamic market and the broader global cosmetics landscape.       The seminar opened with remarks from a former official of the Zhejiang Medical Products Administration, highlighting the importance of compliance in driving high-quality industry development and aligning with global regulatory standards.   Building on this, our speakers shared hands-on insights across both China and

China's Cosmetics Market: Stable Growth and Continuous Regulatory Improvements   China remains the world's largest cosmetics consumer market. In 2025, the industry's total market value exceeded RMB 1.1 trillion (approx. USD 150 billion) for the first time.[1]   China's overall consumer market also continued to grow. Total retail sales of consumer goods reached RMB 50.1 trillion (approx. USD 7 trillion) in 2025, up 3.7% year-on-year. Cosmetics retail sales grew 5.1%, outperforming the overall consumption growth rate and highlighting the sector's continued resilience.[2]   In international trade, China's cosmetics import and export value reached USD 24 billion in 2025, representing a

ZMUni Compliance Centre recently supported Shenzhen CynbioX Biotech in completing the Self-GRAS scientific safety evaluation for its AKG and Ca-AKG products under U.S. FDA GRAS guidelines, culminating in expert consensus. As one of the first domestically fermented AKG products to achieve GRAS compliance, this milestone establishes a strong regulatory foundation for entering the U.S. food market and sets a benchmark for process compliance evaluation in China, reinforcing pathways for international expansion in the nutrition and wellness sector.       Core Breakthrough: First Fermentation-Based Certification in China Alpha-Ketoglutaric Acid (AKG) and its calcium salt form (Ca-AKG) are essential components of

China's cosmetic electronic label (e-label) pilot program continues to expand at the provincial level, with both Shanghai and Zhejiang officially releasing their first batches of pilot companies.   On January 23, 2026, the Shanghai Municipal Medical Products Administration (Shanghai MPA) announced the first batch of 40 pilot companies for the city's cosmetic e-label program. Shanghai Guiyan Technology Co., Ltd., a wholly owned subsidiary of ZMUni Compliance Centre, was selected as a pilot participant, recognizing its compliance expertise and digital service capabilities.   Shortly thereafter, on January 30, 2026, the Zhejiang Provincial Medical Products Administration released its first batch of cosmetic

On December 15, 2025, according to China's National Medical Products Administration (NMPA), Nabsolute Co., Ltd. completed the notification of its first new cosmetic ingredient (NCI) in China under NCI number “国妆原备字20250159”. The ingredient, Hyaluronic Acid/Polyisopropylacrylamide Copolymer, is notable as the first NCI from Thailand to be approved in China.    *image source: China NMPA   We are honored to have partnered with Nabsolute on this project. Leveraging our professional end-to-end services—including preliminary feasibility analysis, advising on potential application scenarios for the new ingredient, and guidance on documentation preparation—we supported the company throughout the successful completion of the entire notification process. We